173 related articles for article (PubMed ID: 22437879)
1. Quantitative analysis and parametric imaging of 18F-labeled monomeric and dimeric RGD peptides using compartment model.
Guo N; Lang L; Gao H; Niu G; Kiesewetter DO; Xie Q; Chen X
Mol Imaging Biol; 2012 Dec; 14(6):743-52. PubMed ID: 22437879
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis and comparison study of [18F]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [68Ga]Ga-NOTA-PRGD2 using a reference tissue model.
Guo N; Lang L; Li W; Kiesewetter DO; Gao H; Niu G; Xie Q; Chen X
PLoS One; 2012; 7(5):e37506. PubMed ID: 22624041
[TBL] [Abstract][Full Text] [Related]
3. (18)F-FPPRGD2 PET/CT: pilot phase evaluation of breast cancer patients.
Iagaru A; Mosci C; Shen B; Chin FT; Mittra E; Telli ML; Gambhir SS
Radiology; 2014 Nov; 273(2):549-59. PubMed ID: 25033190
[TBL] [Abstract][Full Text] [Related]
4. microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4).
Wu Z; Li ZB; Chen K; Cai W; He L; Chin FT; Li F; Chen X
J Nucl Med; 2007 Sep; 48(9):1536-44. PubMed ID: 17704249
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers.
Liu Z; Liu S; Wang F; Liu S; Chen X
Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1296-307. PubMed ID: 19296102
[TBL] [Abstract][Full Text] [Related]
6. MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides.
Jacobson O; Zhu L; Niu G; Weiss ID; Szajek LP; Ma Y; Sun X; Yan Y; Kiesewetter DO; Liu S; Chen X
Mol Imaging Biol; 2011 Dec; 13(6):1224-33. PubMed ID: 21161690
[TBL] [Abstract][Full Text] [Related]
7. A thiol-reactive 18F-labeling agent, N-[2-(4-18F-fluorobenzamido)ethyl]maleimide, and synthesis of RGD peptide-based tracer for PET imaging of alpha v beta 3 integrin expression.
Cai W; Zhang X; Wu Y; Chen X
J Nucl Med; 2006 Jul; 47(7):1172-80. PubMed ID: 16818952
[TBL] [Abstract][Full Text] [Related]
8. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
9. (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression.
Li ZB; Chen K; Chen X
Eur J Nucl Med Mol Imaging; 2008 Jun; 35(6):1100-8. PubMed ID: 18204838
[TBL] [Abstract][Full Text] [Related]
10. 18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression.
Liu S; Liu Z; Chen K; Yan Y; Watzlowik P; Wester HJ; Chin FT; Chen X
Mol Imaging Biol; 2010 Oct; 12(5):530-8. PubMed ID: 19949981
[TBL] [Abstract][Full Text] [Related]
11. N-Succinimidyl 4-[(18)F]-fluoromethylbenzoate-labeled dimeric RGD peptide for imaging tumor integrin expression.
Li W; Lang L; Niu G; Guo N; Ma Y; Kiesewetter DO; Shen B; Chen X
Amino Acids; 2012 Sep; 43(3):1349-57. PubMed ID: 22209865
[TBL] [Abstract][Full Text] [Related]
12. Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide.
Chen X; Tohme M; Park R; Hou Y; Bading JR; Conti PS
Mol Imaging; 2004 Apr; 3(2):96-104. PubMed ID: 15296674
[TBL] [Abstract][Full Text] [Related]
13. (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.
Liu Z; Yan Y; Liu S; Wang F; Chen X
Bioconjug Chem; 2009 May; 20(5):1016-25. PubMed ID: 20540537
[TBL] [Abstract][Full Text] [Related]
14. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
[TBL] [Abstract][Full Text] [Related]
15. MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides.
Chen X; Liu S; Hou Y; Tohme M; Park R; Bading JR; Conti PS
Mol Imaging Biol; 2004; 6(5):350-9. PubMed ID: 15380745
[TBL] [Abstract][Full Text] [Related]
16. 18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression.
Wu Z; Li ZB; Cai W; He L; Chin FT; Li F; Chen X
Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1823-1831. PubMed ID: 17492285
[TBL] [Abstract][Full Text] [Related]
17. Derivation of a compartmental model for quantifying 64Cu-DOTA-RGD kinetics in tumor-bearing mice.
Ferl GZ; Dumont RA; Hildebrandt IJ; Armijo A; Haubner R; Reischl G; Su H; Weber WA; Huang SC
J Nucl Med; 2009 Feb; 50(2):250-8. PubMed ID: 19164244
[TBL] [Abstract][Full Text] [Related]
18. Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging α(v)β(3) integrin levels.
Mittra ES; Goris ML; Iagaru AH; Kardan A; Burton L; Berganos R; Chang E; Liu S; Shen B; Chin FT; Chen X; Gambhir SS
Radiology; 2011 Jul; 260(1):182-91. PubMed ID: 21502381
[TBL] [Abstract][Full Text] [Related]
19. alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide.
Yoshimoto M; Ogawa K; Washiyama K; Shikano N; Mori H; Amano R; Kawai K
Int J Cancer; 2008 Aug; 123(3):709-15. PubMed ID: 18498129
[TBL] [Abstract][Full Text] [Related]
20. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X
J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
